Amper, Ruth P.
HRN: 29-02-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CEFTRIAXONE 1G (VIAL)
05/21/2026
05/27/2026
IV
2G
OD
UTI, DENGUE FEVER
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: